Cosara Diagnostics receives CDSCO license to manufacture SARAGENE® Dengue Test Kit

Cosara Diagnostics Pvt Ltd announces regulatory approval obtained from (Central Drugs Standard Control Organisation) to manufacture and sell SARAGENE® Dengue Test Kit. The tests are now available for sale.

SARAGENE® Dengue Test Kit is an in vitro diagnostic test, based on Real-Time Polymerase Chain Reaction Technology. Test utilizes Co-Diagnostics' patented CoPrimers technology (Satterfield, 2014) (Poritz & Ririe, 2014).

It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.

CoSara is a joint venture company of Synbiotics Limited, a wholly owned subsidiary Ambalal Sarabhai Enterprises Limited and Co- Diagnostics Inc, USA.

Shares of Ambalal Sarabhai Enterprise Ltd., was last trading in BSE at Rs. 29.5 as compared to the previous close of Rs. 29.55. The total number of shares traded during the day was 168825 in over 714 trades.

The stock hit an intraday high of Rs. 30 and intraday low of 29.4. The net turnover during the day was Rs. 4997538.

Source : Equity Bulls

Keywords